Recaps of Past Events

Success Stories

Upcoming Events

InnoSTARS Seattle brings U.S.-China Innovation Collaboration Momentum to new heights

What does Seattle have in common with Chicago, Denver, Atlanta, Houston, San Francisco, and Boston?  It is one of the 7 U.S. cities to host …

Read More →

2018 InnoSTARS Boston Recap

In collaboration with OCS and Cubic Boston, InnoSTARS Boston preliminary competition was successfully completed yesterday, offering an opportunity for 19 pre-selected technology companies to present their innovations and readiness for the …

Read More →

2018 InnoSTARS Houston Recap: Innovation Events Highlight the Needs for Collaboration

The U.S.-China Innovation Alliance (UCIA) hosted the third U.S.-China Innovation and Investment Summit (UCIS) along with the second InnoSTARS pitch competition in Houston, Texas on May 14th …

Read More →

InnoSTARS competition offers winners access to Chinese market

Read More →
1st Place in 2018 InnoSTARS Grand Final
Medical Device, Digital Health and Diagnosis

Who they are

As part of the original vision for the company, namely to contribute to world health through the elimination of needle-based risks and inefficiencies, the company is the first and only World Health Organization prequalified needle-free technology, among numerous other regulatory approvals (FDA, CE, and many others). PharmaJet’s developments during the past decade include notable regulatory achievements (FDA, CE, WHO and multiple other countries), documented clinical trials and field assessments (60 studies in 26 countries, including clinical claims of vaccine superior immune response in a reduced dose intradermal format), and customer experiences (multiple countries), which make it the only commercial state needle-free jet injection technology with the ability to deliver to the intramuscular, subcutaneous, and intradermal tissues.

What they said

“The InnoSTARS experience has been particularly valuable for PharmaJet, helping to expand its network of potential collaboration and investment and trading partners, in China. While PharmaJet had already been collaborating with a division of the Chinese Medical Academy of Sciences for the development of a vaccine prior to the series of InnoSTARS events, we would not have had such a robust view of the market potential for our technology, and multiple partners for various aspects of collaboration. The curation of bringing parties together for a common theme, around well-organized meetings, made the visits very efficient. In addition, the visits to China and extended opportunity to meet other local partners where development and incubation could potentially come together was particularly helpful and insightful into the vast resources China has to offer. Each and every interaction with the individuals at all events, and meetings within China, were extremely professional and productive. To coordinate such meetings as a company would be cost prohibitive and impossible, for the small InnoSTARS participating countries.”

— Heather Potters, Vice-Chairman and Chief Business Development Officer

Soteria Battery Innovation Group
1st Place in 2018 InnoSTARS Industry Final
New Materials

Who they are

Soteria Battery Innovation Group Members are dedicated to enabling portable electric power without the risk of fires, no matter the circumstances. Our material architecture eliminates the spark on the inside of a battery that can cause fires. We are different. Our goal is to ensure that these materials are available to every battery manufacturer with local production from a broad supply base so that every device, whether a hearing aid or a electric bus, can have a battery that is virtually impossible to self-ignite. We will ensure that these materials are used responsibly by setting world-class safety standards so that you, the device manufacturer or consumer, will know that you have the safest electric power source, no matter what.

What they said

“China is a key market for lithium-ion batteries and it is growing very quickly. Soteria aims to expand its consortium in China, pulling together a robust supply chain that will work together to eliminate lithium-ion battery fires. Having the opportunity to travel with InnoSTARS to China to make connections with potential partners and investors has been very valuable to Soteria Battery Innovation Group. We are very thankful to have been a part of InnoSTARS and look forward to participating at the InnoSTARS Alumni Spotlight in Houston.”

— Brian Morin, CEO

Matregenix Inc. 
2018 InnoSTARS Preliminary Winner 
Healthcare and Biotechnology

Who they are

Matregenix Inc. utilizes a platform technology to develop synthetic scaffolds for tissue regeneration. Our patented process and specialized sourced materials enable us to create highly tunable 3D polymeric matrices adaptable to the customized needs of a wide range of medical applications.

What they said

“InnoSTARS offered us a great education opportunity about the Chinese medical device market. During my time in China, I connected with many people who can potentially help us accessing the Chinese market through partnership. While the Chinese market offers great expansion opportunity to grow our business, the complexity of this market makes it impossible to navigate without a Chinese partner. InnoSTARS is facilitating this mission through connecting us with potential Chinese partners.I also represented Matregenix at the 2018 OCS “Talent Make Future” Competition in Gunagzhou. It was my great pleasure experiencing this fruitful and interesting event. It is always inspiring to be with co-conspirators who are out there trying to make the world better place. Excited to be back next year to present our anticipated 2019 milestones.”

— Dr. Sherif Soliman, Chief Executive Officer and CTO

Coming soon…